Chinese Traditional and Herbal Drugs
|
2025, 56(23): 8534-8547
Galactose modified tangeretin biomimetic nanoparticles: Preparation, characterization and pharmacokinetic evaluation
Full
WANG Gaili, GAO Qing, LI Xiaomeng, ZHENG Yan, SUN Jinpeng, CUI Feng
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.23.007
Outline
Objective To prepare galactose modified tangeretin biomimetic nanoparticles (Gal-Tan-BNps), and investigate its physicochemical properties and oral pharmacokinetic behavior. Methods The effects of formulations on the encapsulation efficiency, drug loading and particle size of Gal-Tan-BNps were investigated by single factor experiments. PLGA to drug dosage ratio, N-oleoyl-D-galactosamine quality fraction and poloxamer 188 quality fraction were used as main influencing factors, Box-Behnken design- response surface method (BBD-RSM) was employed to investigate the optimal prescriptions of Gal-Tan-BNps. Encapsulation rate, drug loading, particle size and ζ potential were all determined. Appearance of Gal-Tan-BNps was observed by transmission electron microscopy (TEM), crystal form of tangeretin in Gal-Tan-BNps was analyzed by X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC), drug release behavior of Gal-Tan-BNps was studied by dialysis bag method. The uptake capacity of Gal-Tan-BNps and tangeretin nanoparticles (Tan-Nps) by Caco-2 cells were compared. SD rats were ig administered with Gal-Tan-BNps and Tan-Nps, their main pharmacokinetic parameters and relative bioavailability were also calculated. Results Optimal formulations of Gal-Tan-BNps were as follows: PLGA to drug ratio was 9.33:1, N-oleoyl-D-galactosamine quality fraction was 0.33%, and quality fraction of poloxamer 188 was 0.81%. Encapsulation efficiency, drug loading, particle size and ζ potential of Gal-Tan-BNps were (84.76 ± 1.22)%, (8.04 ± 0.11)%, (190.94 ± 6.60) nm and (-19.92 ± 0.97) mV, respectively. The appearance Gal-Tan-BNps were round or oval vesicles, and tangeretin existed in an amorphous form in Gal-Tan-BNps. The cumulative release rate of Gal-Tan-BNps reached 77.13% in 24 h, and its release behavior accorded with Weibull model including rapid and slow-release period. Caco-2 cells exhibited superior uptake capacity of Gal-Tan-BNps compared to Tan-Nps, and their average density value had significantly difference (P < 0.05). Compared with tangeretin, peak time (tmax) of Gal-Tan-BNps was delayed to (3.06 ± 0.75) h, half-life (t1/2) was prolonged to (5.71 ± 1.47) h, peak contration (Cmax) increased to (1 196.44 ± 230.89) ng/mL, and relative bioavailability increased to 6.43-fold. Gal-Tan-BNps enhanced the bioavailability of tangeretin to a greater extent than that of Tan-BNps. Conclusion Gal-Tan-BNps had a higher encapsulation rate, the cumulative release rate of tangeretin in vitro and oral bioavailability of tangeretin in vivo were improved greatly, which laying the foundation for subsequent research.
tangeretin
/
biomimetic nanoparticles
/
galactose
/
modified
/
Box-Behnken design-response surface method
/
crystal form
/
pharmacokinetic
/
bioavailability
王改利, 高青, 李晓蒙, 郑雁, 孙晋鹏, 崔锋.
半乳糖修饰的桔皮素仿生纳米粒的制备、表征和药动学评价.
中草药,
2025
, 56
(23)
: 8534
-8547
.
DOI: 10.7501/j.issn.0253-2670.2025.23.007
WANG Gaili, GAO Qing, LI Xiaomeng, ZHENG Yan, SUN Jinpeng, CUI Feng.
Galactose modified tangeretin biomimetic nanoparticles: Preparation, characterization and pharmacokinetic evaluation[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(23)
: 8534
-8547
.
DOI: 10.7501/j.issn.0253-2670.2025.23.007
Year 2025 volume 56 Issue 23
33
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.23.007
- Receive Date:2025-07-19
- Online Date:2026-11-13